Publications:

Neoadjuvant-modified FOLFIRINOX vs nab-paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection.

Cancer Medicine

Wolfe, Adam R AR; Prabhakar, Dhivya D; Yildiz, Vedat O VO; Cloyd, Jordan M JM; Dillhoff, Mary M; Abushahin, Laith L; Alexandra Diaz, Dayssy D; Miller, Eric D ED; Chen, Wei W; Frankel, Wendy L WL; Noonan, Anne A; Williams, Terence M TM

Publication Date: 2020-07

Variant appearance in text: PC: D252L

PubMed Link: 32415696

Variant Present in the following documents:

• Main text
• CAM4-9-4711.pdf

View BVdb publication page